Abingdon Health Plc (ABDX) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.181x

Based on the latest financial reports, Abingdon Health Plc (ABDX) has a cash flow conversion efficiency ratio of -0.181x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-959.00K ≈ $-116.68 USD) by net assets (GBX5.30 Million ≈ $644.86 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Abingdon Health Plc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Abingdon Health Plc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Abingdon Health Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Abingdon Health Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Abingdon Health Plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Empresa Distribuidora Electrica Regional SA BA:EMDE	0.011x
SY PUBLIC UTIL -H- (SH3.SG) STU:SH3	-0.751x
Amigo Holdings PLC LSE:AMGO	N/A
ProPhase Labs Inc NASDAQ:PRPH	-3.137x
YY Group Holding Limited Class A Ordinary Shares NASDAQ:YYGH	-0.093x
Tortilla Mexican Grill PLC LSE:MEX	-0.810x
Fast Finance SA WAR:FFI	0.388x
Mavshack publ AB ST:MAV	-0.181x

Annual Cash Flow Conversion Efficiency for Abingdon Health Plc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Abingdon Health Plc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Abingdon Health Plc (ABDX) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX5.30 Million ≈ $644.86	GBX-3.18 Million ≈ $-387.16	-0.600x	+18.61%
2024-06-30	GBX2.25 Million ≈ $273.64	GBX-1.66 Million ≈ $-201.85	-0.738x	-321.52%
2023-06-30	GBX3.01 Million ≈ $366.11	GBX1.00 Million ≈ $121.91	0.333x	+127.69%
2022-06-30	GBX6.43 Million ≈ $782.59	GBX-7.74 Million ≈ $-941.13	-1.203x	-99.19%
2021-06-30	GBX21.33 Million ≈ $2.59K	GBX-12.88 Million ≈ $-1.57K	-0.604x	-179.22%
2020-06-30	GBX2.75 Million ≈ $334.47	GBX2.10 Million ≈ $254.90	0.762x	+610.73%
2019-06-30	GBX6.09 Million ≈ $740.58	GBX-908.25K ≈ $-110.51	-0.149x	+65.99%
2018-06-30	GBX5.81 Million ≈ $707.29	GBX-2.55 Million ≈ $-310.29	-0.439x	-103.06%
2016-12-31	GBX-115.66K ≈ $-14.07	GBX-1.66 Million ≈ $-201.83	14.342x	--

About Abingdon Health Plc

LSE:ABDX UK Diagnostics & Research

Market Cap

$351.31K

GBX2.89 Billion GBX

Market Cap Rank

#30952 Global

#959 in UK

Share Price

GBX11.50

Change (1 day)

+0.00%

52-Week Range

GBX5.25 - GBX12.75

All Time High

GBX125.63